Injectable rilpivirine shows promise in phase I trials – but may work better for anal than vaginal sex
Tenofovir gel use associated with lower HSV-2 risk in women
Injectable cabotegravir makes progress towards human efficacy studies: doubts about injectable rilpivirine
Second European PrEP study closes placebo arm early due to high effectiveness
High effectiveness seen in English PrEP trial
CBT counselling significantly increases adherence among participants in HIV PrEP study
Gay men interested in taking PrEP already report high-risk behaviour
Good adherence seen in study of intermittent PrEP
Overall PrEP effectiveness in iPrEx OLE study 50%, but 100% in those taking four or more doses a week
